CAD 0.1
(-23.08%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 181.7 Thousand CAD | 67.29% |
2022 | 108.61 Thousand CAD | 3.87% |
2021 | 104.56 Thousand CAD | 34.5% |
2020 | 77.74 Thousand CAD | 29.4% |
2019 | 60.07 Thousand CAD | 64.23% |
2018 | 36.58 Thousand CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 149.71 Thousand CAD | 13.11% |
2024 Q3 | 122.63 Thousand CAD | -18.09% |
2024 Q1 | 132.36 Thousand CAD | -27.15% |
2023 Q3 | 129.91 Thousand CAD | 29.92% |
2023 Q1 | 132.28 Thousand CAD | 21.79% |
2023 FY | 181.7 Thousand CAD | 67.29% |
2023 Q2 | 99.99 Thousand CAD | -24.41% |
2023 Q4 | 181.7 Thousand CAD | 39.86% |
2022 Q2 | 145.52 Thousand CAD | 13.64% |
2022 FY | 108.61 Thousand CAD | 3.87% |
2022 Q4 | 108.61 Thousand CAD | -14.45% |
2022 Q3 | 126.96 Thousand CAD | -12.76% |
2022 Q1 | 128.06 Thousand CAD | 22.47% |
2021 Q3 | 146.03 Thousand CAD | 0.0% |
2021 FY | 104.56 Thousand CAD | 34.5% |
2021 Q4 | 104.56 Thousand CAD | -28.4% |
2020 FY | 77.74 Thousand CAD | 29.4% |
2019 FY | 60.07 Thousand CAD | 64.23% |
2018 FY | 36.58 Thousand CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Biosenta Inc. | 7.96 Million CAD | 97.718% |